Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Exclusive License AgreementExclusive License Agreement • August 14th, 2002 • United Therapeutics Corp • Pharmaceutical preparations • Maryland
Contract Type FiledAugust 14th, 2002 Company Industry JurisdictionThis Exclusive License Agreement (“Agreement”) is made and entered into this 17th day of April 2002, by and between AltaRex Corp., a corporation organized and existing under Business Corporations Act (Alberta), Canada, with executive offices located at 610 Lincoln Street, Waltham, Massachusetts 02451 (“AltaRex”) and Unither Pharmaceuticals, Inc., a wholly-owned subsidiary of United Therapeutics Corporation, a corporation organized and existing under the laws of the State of Delaware, located at 1110 Spring Street, Silver Spring, Maryland 20910, U.S.A. (hereinafter referred to as “UP”). AltaRex and UP may be referred to in this Agreement each individually as a “party” and jointly as the “parties.”